Connection

William Creasman to Adult

Back to Details
This is a "connection" page, showing publications William Creasman has written about Adult.
William Creasman
Connection Strength
0.576
Adult
  1. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2017 06; 145(3):519-525.
    View in: PubMed
    Score: 0.040
  2. Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82.
    View in: PubMed
    Score: 0.038
  3. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-43.
    View in: PubMed
    Score: 0.019
  4. Carcinoma of the vulva. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:7-26.
    View in: PubMed
    Score: 0.016
  5. Carcinoma of the vagina. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:27-39.
    View in: PubMed
    Score: 0.016
  6. Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:79-118.
    View in: PubMed
    Score: 0.016
  7. Gestational trophoblastic diseases. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:167-74.
    View in: PubMed
    Score: 0.016
  8. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6.
    View in: PubMed
    Score: 0.015
  9. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2002 Jan; 84(1):32-5.
    View in: PubMed
    Score: 0.014
  10. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecol Oncol. 2021 03; 160(3):660-668.
    View in: PubMed
    Score: 0.013
  11. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol. 2001 Jan; 184(2):64-9.
    View in: PubMed
    Score: 0.013
  12. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg. 1999 Jun; 188(6):670-5.
    View in: PubMed
    Score: 0.012
  13. An experience with estrogen replacement therapy in breast cancer survivors. Int J Fertil Womens Med. 1999 Jun-Aug; 44(4):186-92.
    View in: PubMed
    Score: 0.012
  14. Is there an association between hormone replacement therapy and breast cancer? J Womens Health. 1998 Dec; 7(10):1231-46.
    View in: PubMed
    Score: 0.011
  15. The National Cancer Data Base report on cancer of the vagina. Cancer. 1998 Sep 01; 83(5):1033-40.
    View in: PubMed
    Score: 0.011
  16. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997 Aug 01; 80(3):505-13.
    View in: PubMed
    Score: 0.010
  17. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 1997 Aug; 66(2):171-8.
    View in: PubMed
    Score: 0.010
  18. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07; 390(10103):1654-1663.
    View in: PubMed
    Score: 0.010
  19. Replacement therapy for breast cancer survivors. A pilot study. Cancer. 1995 Nov 15; 76(10 Suppl):2075-8.
    View in: PubMed
    Score: 0.009
  20. Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.009
  21. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 1995 Jun; 57(3):412-6.
    View in: PubMed
    Score: 0.009
  22. Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. Gynecol Oncol. 1994 Nov; 55(2):313-7.
    View in: PubMed
    Score: 0.008
  23. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8.
    View in: PubMed
    Score: 0.008
  24. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol. 2013 May; 129(2):277-84.
    View in: PubMed
    Score: 0.008
  25. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992 Apr; 79(4):490-7.
    View in: PubMed
    Score: 0.007
  26. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol. 1991 Dec; 78(6):1027-32.
    View in: PubMed
    Score: 0.007
  27. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol. 1991 Jan; 40(1):42-5.
    View in: PubMed
    Score: 0.006
  28. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990 Jun; 37(3):390-5.
    View in: PubMed
    Score: 0.006
  29. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989 Oct; 7(10):1462-8.
    View in: PubMed
    Score: 0.006
  30. How good (or bad) is the Pap smear? J S C Med Assoc. 1989 Oct; 85(10):459-62.
    View in: PubMed
    Score: 0.006
  31. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
    View in: PubMed
    Score: 0.006
  32. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94.
    View in: PubMed
    Score: 0.005
  33. Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.
    View in: PubMed
    Score: 0.005
  34. Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic "lid" after radical pelvic resection. Am J Obstet Gynecol. 1988 Jan; 158(1):158-61.
    View in: PubMed
    Score: 0.005
  35. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007 Aug; 106(2):362-9.
    View in: PubMed
    Score: 0.005
  36. Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol. 1987 Feb; 26(2):160-8.
    View in: PubMed
    Score: 0.005
  37. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb; 69(2):151-5.
    View in: PubMed
    Score: 0.005
  38. Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol. 1987 Jan; 26(1):11-8.
    View in: PubMed
    Score: 0.005
  39. Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S145-60.
    View in: PubMed
    Score: 0.005
  40. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S161-92.
    View in: PubMed
    Score: 0.005
  41. Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S193-203.
    View in: PubMed
    Score: 0.005
  42. Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S29-42.
    View in: PubMed
    Score: 0.005
  43. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
    View in: PubMed
    Score: 0.005
  44. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S7-27.
    View in: PubMed
    Score: 0.005
  45. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol. 1986 Nov; 155(5):964-9.
    View in: PubMed
    Score: 0.005
  46. Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1985 Jun 15; 152(4):418-23.
    View in: PubMed
    Score: 0.004
  47. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol. 1985 Jun; 21(2):220-7.
    View in: PubMed
    Score: 0.004
  48. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol. 1985 Apr 01; 151(7):922-32.
    View in: PubMed
    Score: 0.004
  49. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. Am J Obstet Gynecol. 1984 Dec 15; 150(8):927-31.
    View in: PubMed
    Score: 0.004
  50. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol. 1984 Nov; 64(5):689-94.
    View in: PubMed
    Score: 0.004
  51. Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report. Am J Obstet Gynecol. 1984 Aug 01; 149(7):796-8.
    View in: PubMed
    Score: 0.004
  52. A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol. 1984 Jun; 7(3):257-60.
    View in: PubMed
    Score: 0.004
  53. Cryosurgery in the management of cervical intraepithelial neoplasia. Obstet Gynecol. 1984 Feb; 63(2):145-9.
    View in: PubMed
    Score: 0.004
  54. Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy. Am J Obstet Gynecol. 1983 Oct 15; 147(4):369-75.
    View in: PubMed
    Score: 0.004
  55. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:41-78.
    View in: PubMed
    Score: 0.004
  56. Carcinoma of the Fallopian tube. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:119-33.
    View in: PubMed
    Score: 0.004
  57. Carcinoma of the ovary. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:135-66.
    View in: PubMed
    Score: 0.004
  58. Intracavitary Corynebacterium parvum for treatment of malignant effusions. Gynecol Oncol. 1983 Aug; 16(1):6-14.
    View in: PubMed
    Score: 0.004
  59. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol. 1983 Mar 01; 145(5):606-13.
    View in: PubMed
    Score: 0.004
  60. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol. 1983 Jan; 61(1):87-94.
    View in: PubMed
    Score: 0.004
  61. A trial of prophylactic cefamandole in extended gynecologic surgery. Obstet Gynecol. 1982 Mar; 59(3):309-14.
    View in: PubMed
    Score: 0.004
  62. Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding. Gynecol Oncol. 1981 Dec; 12(3):319-27.
    View in: PubMed
    Score: 0.003
  63. The abnormal Pap smear--what to do next? Cancer. 1981 Jul 15; 48(2 Suppl):515-22.
    View in: PubMed
    Score: 0.003
  64. Conservative management of cervical intraepithelial neoplasia. Clin Obstet Gynecol. 1980 Mar; 23(1):281-91.
    View in: PubMed
    Score: 0.003
  65. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol. 1980 Mar; 55(3):363-70.
    View in: PubMed
    Score: 0.003
  66. Unusual metastasis in carcinoma of the cervix uteri. Surg Gynecol Obstet. 1979 May; 148(5):728-30.
    View in: PubMed
    Score: 0.003
  67. Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol. 1975 Oct 15; 123(4):349-55.
    View in: PubMed
    Score: 0.002
  68. Meningeal carcinomatosis secondary to advanced squamous cell carcinoma of the cervix: a case report. Meningeal metastasis of advenced cervical cancer. Gynecol Oncol. 1975 Sep; 3(3):201-4.
    View in: PubMed
    Score: 0.002
  69. Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 1995 Jul; 13(7):1589-99.
    View in: PubMed
    Score: 0.002
  70. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994 Apr; 170(4):974-9; discussion 979-80.
    View in: PubMed
    Score: 0.002
  71. Experience with a mass closure technique using continuous looped polyglyconate absorbable suture. J Am Coll Surg. 1994 Feb; 178(2):177-80.
    View in: PubMed
    Score: 0.002
  72. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynecol. 1973 Apr; 41(4):501-6.
    View in: PubMed
    Score: 0.002
  73. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993 Feb 15; 71(4 Suppl):1702-9.
    View in: PubMed
    Score: 0.002
  74. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer. 1993 Jan 15; 71(2 Suppl):606-14.
    View in: PubMed
    Score: 0.002
  75. Carcinoma in situ of the cervix. An analysis of 861 patients. Obstet Gynecol. 1972 Mar; 39(3):373-80.
    View in: PubMed
    Score: 0.002
  76. Antepartum pulmonary embolism. Am J Obstet Gynecol. 1972 Feb 15; 112(4):476-86.
    View in: PubMed
    Score: 0.002
  77. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992 Jan; 166(1 Pt 1):50-3.
    View in: PubMed
    Score: 0.002
  78. Carcinoma of the ovary associated with pregnancy. Obstet Gynecol. 1971 Jul; 38(1):111-6.
    View in: PubMed
    Score: 0.002
  79. Running mass closure of abdominal wounds using absorbable looped suture. J Gynecol Surg. 1991; 7(2):107-10.
    View in: PubMed
    Score: 0.002
  80. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Dec; 35(3):314-20.
    View in: PubMed
    Score: 0.002
  81. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989 Dec; 35(3):352-7.
    View in: PubMed
    Score: 0.002
  82. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol. 1989 Oct; 35(1):93-8.
    View in: PubMed
    Score: 0.001
  83. Evaluation of the atypical Pap smear. Am J Obstet Gynecol. 1987 Sep; 157(3):544-9.
    View in: PubMed
    Score: 0.001
  84. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986 Oct; 46(10):5419-25.
    View in: PubMed
    Score: 0.001
  85. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer. 1986 May 01; 57(9):1725-30.
    View in: PubMed
    Score: 0.001
  86. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986 Mar; 67(3):326-30.
    View in: PubMed
    Score: 0.001
  87. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report). Cancer. 1985 Jul 15; 56(2):243-8.
    View in: PubMed
    Score: 0.001
  88. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 1983 Aug 15; 52(4):626-32.
    View in: PubMed
    Score: 0.001
  89. Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. Am J Clin Oncol. 1983 Jun; 6(3):273-5.
    View in: PubMed
    Score: 0.001
  90. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol. 1979 Jul; 96(1):171-83.
    View in: PubMed
    Score: 0.001
  91. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979 Apr 01; 133(7):825-32.
    View in: PubMed
    Score: 0.001
  92. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 01; 133(5):537-47.
    View in: PubMed
    Score: 0.001
  93. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 01; 133(5):525-36.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.